Company / SG&A Expense
U.S. Physical Therapy, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$69.3M
FY2025
5-year range
$42.0M / $69.3M
FY2021-FY2025
Trend
+18.8%
vs FY2024
Sector context
#140 of 158
Health Care
What the data says
U.S. Physical Therapy, Inc.'s sg&a expense of $69M is lower than 89% of companies in the Health Care sector (FY2025). SG&A Expense has increased for 3 consecutive years, from $42M in FY2022 to $69M in FY2025.
Based on SEC 10-K filings.
$69M in FY2025 with a 5-year CAGR of +10.9%.
Increased from $52M to $69M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +18.1%
- 5-Year CAGR
- +10.9%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 158This company $69.3M Sector average $175.9B
▼
-100.0% below sector average
Key checks
Key Insights
- U.S. Physical Therapy, Inc.'s sg&a expense has grown for 3 consecutive years.
- 5-year CAGR of +10.9%, indicating consistent growth.
- In FY2025, sg&a expense increased 18.8% year-over-year.
- Ranks #140 out of 158 companies in the Health Care sector.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $69.3M | +18.8% |
| FY2024 | $58.3M | +12.2% |
| FY2023 | $52.0M | +23.6% |
| FY2022 | $42.0M | -6.7% |
| FY2021 | $45.0M | +8.9% |
| FY2020 | $41.3M | -8.2% |
| FY2019 | $45.0M | +38.7% |
| FY2018 | $32.5M | +4.5% |
| FY2017 | $31.1M | +2.2% |
| FY2016 | $30.4M | -2.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026